(Q85084285)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

MART-1- and gp100-expressing and -non-expressing melanoma cells are equally proliferative in tumors and clonogenic in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Mariana Aris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Mariana Rodríguez Zubieta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Marina Colombo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Juan Martín Arriaga

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Michele Bianchini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Myriam Alperovich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Alicia I Bravo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

María M Barrio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

José Mordoh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

English

0 references

publication date

13 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

365-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993558%20AND%20SRC:MED&resulttype=core&format=json

The expression of progesterone receptors coincides with an arrest of DNA synthesis in human breast cancer

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

A phase I study of an allogeneic cell vaccine (VACCIMEL) with GM-CSF in melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Model predicting survival in stage I melanoma based on tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

The human tumor clonogenic assay as a model system in cell biology

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Differential expression of stem-cell-associated markers in human hair follicle epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Efficient tumour formation by single human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Adoptive cell therapy for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Modulation of T-cell activation by malignant melanoma initiating cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Functionally impaired HIV-specific CD8 T cells show high affinity TCR-ligand interactions.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of d

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.312

7 January 2021